Tower Research Capital LLC (Trc) Ensysce Biosciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.05 - $153.6 $618 - $1.9 Million	12,369 Added 403.69%	15,433 $3,000
Q2 2022 Aug 15, 2022	SELL	$100.8 - $345.6 $721,929 - $2.48 Million	-7,162 Reduced 70.04%	3,064 $3,000
Q1 2022 May 12, 2022	SELL	$230.4 - $1140.0 $5.12 Million - $25.3 Million	-22,227 Reduced 68.49%	10,226 $12,000
Q4 2021 Feb 14, 2022	BUY	$300.0 - $1228.8 $6.56 Million - $26.9 Million	21,860 Added 206.36%	32,453 $153,000
Q3 2021 Nov 15, 2021	BUY	$696.0 - $3477.6 $7.37 Million - $36.8 Million	10,593 New	10,593 $32,000

100

Ticker ENSC
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,918,900
Market Cap $1.25M
Description
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abu...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.